-
Data-driven analysis identifies novel modulation of social behavior in female mice witnessing chronic social defeat stress Biol. Psychiatry (IF 9.6) Pub Date : 2024-12-03 Heike Schuler, Rand S. Eid, Serena Wu, Yiu-Chung Tse, Vedrana Cvetkovska, Joëlle Lopez, Rosalie Quinn, Delong Zhou, Juliet Meccia, Laurence Dion-Albert, Shannon N. Bennett, Emily L. Newman, Brian C. Trainor, Catherine J. Peña, Caroline Menard, Rosemary C. Bagot
Chronic social defeat stress is a widely used depression model in male mice. Several proposed adaptations extend this model to females with variable, often marginal effects. We examine if the widely used male-defined metrics of stress are suboptimal in females witnessing defeat.
-
-
-
-
-
-
Separating the Mechanisms of Mindfulness Meditation and Placebo Biol. Psychiatry (IF 9.6) Pub Date : 2024-11-27 Belina Rodrigues, Luana Colloca
-
Childhood Adversity and the Pace of Brain Development Biol. Psychiatry (IF 9.6) Pub Date : 2024-11-27 Sarah Whittle
-
You Are What You Eat, and You Behave Accordingly: How B12 Influences the Occurrence of Neuropsychiatric Disorders via Epigenetic Mechanisms Biol. Psychiatry (IF 9.6) Pub Date : 2024-11-27 Arturo Marroquin Rivera, Benoit Labonté
-
Along Came the DSM—Melancholic Depression, the Dexamethasone Suppression Test, and How Psychiatry Lost the Brain Biol. Psychiatry (IF 9.6) Pub Date : 2024-11-27 Joshua C. Eloge, Joseph J. Cooper, David A. Ross
-
Loneliness and Social Connection in the Mental Health Crisis Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-29 Julianne Holt-Lunstad, Katy Sine
-
Building Resilience: The Stress Response as a Driving Force for Neuroplasticity and Adaptation Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-22 Erno J. Hermans, Talma Hendler, Raffael Kalisch
People exhibit an extraordinary capacity to adjust to stressful situations. Here, we argue that the acute stress response is a major driving force behind this adaptive process. In addition to immediately freeing energy reserves, facilitating a rapid and robust neurocognitive response, and helping to reinstate homeostasis, the stress response also critically regulates neuroplasticity. Therefore, understanding
-
Multiomics Analysis of the Molecular Response to Glucocorticoids: Insights Into Shared Genetic Risk From Psychiatric to Medical Disorders Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-10 Janine Knauer-Arloth, Anastasiia Hryhorzhevska, Elisabeth B. Binder
Alterations in the effects of glucocorticoids have been implicated in mediating some of the negative health effects associated with chronic stress, including increased risk for psychiatric disorders and cardiovascular and metabolic diseases. In this study, we investigated how genetic variants influence gene expression and DNA methylation in response to glucocorticoid receptor (GR) activation and their
-
Association of Allostatic Load With Depression, Anxiety, and Suicide: A Prospective Cohort Study Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-10 Yifan Gou, Shiqiang Cheng, Meijuan Kang, Ruixue Zhou, Chen Liu, Jingni Hui, Ye Liu, Bingyi Wang, Panxing Shi, Feng Zhang
Allostatic load (AL) is an objective measure of the biological components of chronic stress in clinical practice, which potentially influence depression, anxiety, and suicide. In this study, we investigated the association between AL and these mental disorders.
-
Astrogliosis Marker [11C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive Symptoms Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-10 Joeffre Braga, Emily J.Y. Kuik, Mariel Lepra, Pablo M. Rusjan, Stephen J. Kish, Erica L. Vieira, Zahra Nasser, Natasha Verhoeff, Neil Vasdev, Thomas Chao, Michael Bagby, Isabelle Boileau, Stefan Kloiber, M. Ishrat Husain, Nathan Kolla, Yuko Koshimori, Khunsa Faiz, Wei Wang, Jeffrey H. Meyer
After acute COVID-19, 5% of people experience persistent depressive symptoms and reduced cognitive function (COVID-DC). Theoretical models propose that astrogliosis is important in long COVID, but measures primarily indicative of astrogliosis have not been studied in the brain of long COVID or COVID-DC. The objective of the current study was to measure [11C]SL25.1188 total distribution volume ([11C]SL25
-
Genome-Wide Association Study Meta-Analysis of 9619 Cases With Tic Disorders Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-09 Nora I. Strom, Matthew W. Halvorsen, Jakob Grove, Bergrún Ásbjörnsdóttir, Pétur Luðvígsson, Ólafur Thorarensen, Elles de Schipper, Julia Bäckmann, Per Andrén, Chao Tian, PGC TS Working Group, Dongmei Yu, Jae Hoon Sul, Fotis Tsetsos, Muhammad S. Nawaz, Alden Y. Huang, Ivette Zelaya, Cornelia Illmann, Lisa Osiecki, Sabrina M. Darrow, Matthew E. Hirschtritt, Erica Greenberg, Kirsten R. Muller-Vahl, Manfred
Despite the significant personal and societal burden of tic disorders (TDs), treatment outcomes remain modest, necessitating a deeper understanding of their etiology. Family history is the biggest known risk factor, and identifying risk genes could accelerate progress in the field.
-
Prophylactic (R,S)-ketamine and (2S,6S)-hydroxynorketamine Decrease Fear Expression by Differentially Modulating Fear Neural Ensembles Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-09 Alessia Mastrodonato, Michelle Jin, Noelle Kee, Marcos Lanio, Juliana Tapia, Liliette Quintana, Andrea Muñoz Zamora, Shi-Xian Deng, Xiaoming Xu, Donald W. Landry, Christine A. Denny
We previously reported that a single injection of (R,S)-ketamine or its metabolite (2S,6S)-hydroxynorketamine (HNK) prior to stress attenuated learned fear. However, whether these drugs attenuate learned fear through divergent or convergent effects on neural activity remains to be determined.
-
Mapping Lesion-Related Human Aggression to a Common Brain Network Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-04 Shaoling Peng, Frederic L.W.V.J. Schaper, Shira Cohen-Zimerman, Gillian N. Miller, Jing Jiang, Rob P.W. Rouhl, Yasin Temel, Shan H. Siddiqi, Jordan Grafman, Michael D. Fox, Alexander L. Cohen
Aggression exacts a significant toll on human societies and is highly prevalent among neuropsychiatric patients. The neural mechanisms of aggression are unclear and treatment options are limited.
-
Stress Molecular Signaling in Interaction With Cognition Biol. Psychiatry (IF 9.6) Pub Date : 2024-10-04 Justina F. Lugenbühl, Eva M.G. Viho, Elisabeth B. Binder, Nikolaos P. Daskalakis
Exposure to stressful life events is associated with a high risk of developing psychiatric disorders with a wide variety of symptoms. Cognitive symptoms in stress-related psychiatric disorders can be particularly challenging to understand, both for those experiencing them and for health care providers. To gain insights, it is important to capture stress-induced structural, epigenomic, transcriptomic
-
-
-
-
-
-
Under the Microscope: Nerve Glue and the Evolution of Psychiatric Neuroscience Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-30 Sukumar Vijayaraghavan, David A. Ross, Andrew M. Novick
-
Substance- and Cell-Specific Roles of Mesolimbic Dopamine D3 Receptors Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-30 Freja Herborg
-
Electroencephalographic Analysis of Sleep-Related Subcortical Neuron Activity: A Biomarker for Cocaine Addiction? Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-30 Ginevra D’Ottavio
-
Leaving an Impression: Morphine-Induced Disruptions to Brain Connectivity Persist Through Abstinence to Prime Future Drug Responses Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-30 Caleb J. Browne
-
Wrapping Our Minds Around Perineuronal Nets: Brevican Influences Nucleus Accumbens Parvalbumin Interneuron Synaptic and Behavioral Plasticity Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-30 Loren D. Peeters, Brad A. Grueter
-
Sex-Specific Effects of Anxiety on Cognition and Activity-Dependent Neural Networks: Insights From (Female) Mice and (Wo)men Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-28 Holly C. Hunsberger, Seonjoo Lee, Michelle Jin, Marcos Lanio, Alicia Whye, Jiook Cha, Miranda Scarlata, Louise C. Matthews, Keerthana Jayaseelan, Christine A. Denny, Alzheimer’s Disease Neuroimaging Initiative
Neuropsychiatric symptoms, such as depression and anxiety, are observed in 90% of patients with Alzheimer’s disease (AD), two-thirds of whom are women. Neuropsychiatric symptoms usually manifest long before AD onset creating a therapeutic opportunity. Here, we examined the impact of anxiety on AD progression and the underlying brainwide neuronal mechanisms.
-
Value Modulation of Self-Defeating Impulsivity Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-28 Zhe Liu, Robert Reiner, Yonatan Loewenstein, Eran Lottem
Impulse control is a critical aspect of cognitive functioning. Intuitively, whether an action is executed prematurely depends on its associated reward, yet the link between value and impulsivity remains poorly understood. Three frameworks for impulsivity offer contrasting views: impulsive behavior may be valuable because it is associated with hidden internal reward (e.g., reduction of mental effort)
-
Differential Functions of Oxytocin Receptor–Expressing Neurons in the Ventromedial Hypothalamus in Social Stress Responses: Induction of Adaptive and Maladaptive Coping Behaviors Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-27 Naranbat Nasanbuyan, Masahide Yoshida, Ayumu Inutsuka, Yuki Takayanagi, Shigeki Kato, Shizu Hidema, Katsuhiko Nishimori, Kazuto Kobayashi, Tatsushi Onaka
The flexibility to adjust actions and attitudes in response to varying social situations is a fundamental aspect of adaptive social behavior. Adaptive social behaviors influence an individual’s vulnerability to social stress. While it has been proposed that oxytocin is a facilitator of active coping behaviors during social stress, the exact mechanisms remain unknown.
-
The Future of Schizophrenia Care: A Lived Experience–Based Call for Innovation Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-23 Brandon Staglin
-
Recent Breakthroughs in Genetic and Brain Structural Correlates of Suicidal Behaviors: A Short Review Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-19 Zuriel Ceja, Laura S. van Velzen, Adrian I. Campos, Neda Jahanshad, Sarah E. Medland, Alexis C. Edwards, Lianne Schmaal, Miguel E. Rentería
Suicide accounts for more than 700,000 deaths annually and is the fourth leading cause of death among individuals aged 15 to 29 years. Despite years of research to understand the etiology and pathophysiology of suicidal behavior, many questions remain unresolved—for example, whether suicidal behavior has a unique genetic or neurobiological basis and how these differ from related psychiatric conditions
-
Noradrenergic Mechanisms and Circuitry of Hyperkatifeia in Alcohol Use Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-18 Florence P. Varodayan, Chloe M. Erikson, Marcis V. Scroger, Marisa Roberto
Hyperkatifeia, the manifestation of emotional distress or pain, is a conceptual framework gaining traction throughout the alcohol and other substance use fields as an important driver of addiction. It is well known that previous or current negative life experiences can serve as powerful motivators for excessive alcohol consumption and precipitate the development of an alcohol use disorder (AUD). A
-
Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-16 Anna Onisiforou, Andria Michael, Markos Apostolakis, Elmar Mammadov, Angeliki Mitka, Maria A. Kalatta, Morfeas Koumas, Andrea Georgiou, Andreas Chatzittofis, Georgia Panayiotou, Polymnia Georgiou, Carlos A. Zarate, Panos Zanos
Opioid use disorder (OUD) has reached epidemic proportions, with many countries facing high levels of opioid use and related fatalities. Although currently prescribed medications for OUD are considered lifesaving, they inadequately address negative affect and cognitive impairment, resulting in high relapse rates to nonmedical opioid use even years after drug cessation (protracted abstinence). Evidence
-
Transcranial Magnetic Stimulation–Induced Plasticity Improving Cognitive Control in Obsessive-Compulsive Disorder, Part II: Task-Based Neural Predictors of Treatment Response Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-14 Tjardo S. Postma, Sophie M.D.D. Fitzsimmons, Chris Vriend, Neeltje M. Batelaan, Ysbrand D. van der Werf, Odile A. van den Heuvel
Repetitive transcranial magnetic stimulation (rTMS) has the potential to increase the clinical effect of exposure with response prevention psychotherapy for obsessive-compulsive disorder (OCD). We investigated the use of task-based functional magnetic resonance imaging for predicting clinical outcomes to different rTMS protocols combined with exposure with response prevention in OCD.
-
A Population-Based Multigenerational Family Coaggregation Study of Severe Infections and Obsessive-Compulsive Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-14 Josep Pol-Fuster, Lorena Fernández de la Cruz, Jan C. Beucke, Eva Hesselmark, James J. Crowley, Elles de Schipper, Isabell Brikell, Zheng Chang, Brian M. D’Onofrio, Henrik Larsson, Paul Lichtenstein, Ralf Kuja-Halkola, David Mataix-Cols
Postinfectious autoimmune processes have been proposed as potential causal risk factors for obsessive-compulsive disorder (OCD). In this large population-based study, we aimed to clarify the familial coaggregation pattern between severe infections and OCD across clusters of relatives with varying degrees of relatedness.
-
Social Homeostasis and Psychoactive Drugs: What Can We Learn From Opioid and Amphetamine Drug Challenge Studies in Humans? Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-12 Anya K. Bershad, Harriet de Wit
Social disequilibrium, or disrupted social homeostasis, underlies many behavioral disorders, including problematic drug use. One way to study the relationship between drug use and social homeostasis is to determine whether single doses of psychoactive drugs relieve some of the discomfort of social isolation and promote social connection. In this narrative review, we discuss challenges and opportunities
-
A Computational Account of the Development and Evolution of Psychotic Symptoms Biol. Psychiatry (IF 9.6) Pub Date : 2024-09-10 Albert Powers, Phillip A. Angelos, Alexandria Bond, Emily Farina, Carolyn Fredericks, Jay Gandhi, Maximillian Greenwald, Gabriela Hernandez-Busot, Gabriel Hosein, Megan Kelley, Catalina Mourgues, William Palmer, Julia Rodriguez-Sanchez, Rashina Seabury, Silmilly Toribio, Raina Vin, Jeremy Weleff, Scott Woods, David Benrimoh
The mechanisms of psychotic symptoms such as hallucinations and delusions are often investigated in fully formed illness, well after symptoms emerge. These investigations have yielded key insights but are not well positioned to reveal the dynamic forces underlying symptom formation itself. Understanding symptom development over time would allow us to identify steps in the pathophysiological process
-
Computational Phenotyping of Aberrant Belief Updating in Individuals With Schizotypal Traits and Schizophrenia Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-30 Nace Mikus, Claus Lamm, Christoph Mathys
Psychotic experiences are thought to emerge from various interrelated patterns of disrupted belief updating, such as overestimating the reliability of sensory information and misjudging task volatility, yet these substrates have never been jointly addressed under one computational framework, and it is not clear to what degree they reflect trait-like computational patterns.
-
Quantification of Glutathione and Its Associated Spontaneous Neuronal Activity in Major Depressive Disorder and Obsessive-Compulsive Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-30 Sang Won Lee, Seungho Kim, Yongmin Chang, Hyunsil Cha, Ralph Noeske, Changho Choi, Seung Jae Lee
Glutathione (GSH) is a crucial antioxidant in the human brain. Although proton magnetic resonance spectroscopy using the Mescher-Garwood point-resolved spectroscopy sequence is highly recommended, limited literature has measured cortical GSH using this method in major psychiatric disorders.
-
Regional Structural-Functional Connectivity Coupling in Major Depressive Disorder Is Associated With Neurotransmitter and Genetic Profiles Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-30 Tongpeng Chu, Xiaopeng Si, Haizhu Xie, Heng Ma, Yinghong Shi, Wei Yao, Dong Xing, Feng Zhao, Fanghui Dong, Qun Gai, Kaili Che, Yuting Guo, Danni Chen, Dong Ming, Ning Mao
Abnormalities in structural-functional connectivity (SC-FC) coupling have been identified globally in patients with major depressive disorder (MDD). However, investigations have neglected the variability and hierarchical distribution of these abnormalities across different brain regions. Furthermore, the biological mechanisms that underlie regional SC-FC coupling patterns are not well understood.
-
Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-30 Pejman Sehatpour, Joshua T. Kantrowitz
Cognitive impairment associated with schizophrenia (CIAS) and related deficits in learning (plasticity) are among the leading causes of disability in schizophrenia. Despite this, there are no Food and Drug Administration–approved treatments for CIAS, and the development of treatments has been limited by numerous phase 2/3 failures of compounds that showed initial promise in small-scale studies. NMDA-type
-
Mindfulness Meditation and Placebo Modulate Distinct Multivariate Neural Signatures to Reduce Pain Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-30 Gabriel Riegner, Jon Dean, Tor D. Wager, Fadel Zeidan
Rather than a passive reflection of nociception, pain is shaped by the interplay between one’s experiences, current cognitive-affective states, and expectations. The placebo response, a paradoxical yet reliable phenomenon, is postulated to reduce pain by engaging mechanisms shared with active therapies. It has been assumed that mindfulness meditation, practiced by sustaining nonjudgmental awareness
-
Long-Term Safety and Efficacy of Focused Ultrasound Capsulotomy for Obsessive-Compulsive Disorder and Major Depressive Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-24 Clement Hamani, Benjamin Davidson, Jennifer S. Rabin, Maged Goubran, Lyndon Boone, Kullervo Hynynen, Emmanuel De Schlichting, Ying Meng, Yuexi Huang, Ryan M. Jones, Anusha Baskaran, Tulip Marawi, Margaret Anne Richter, Anthony Levitt, Sean M. Nestor, Peter Giacobbe, Nir Lipsman
Magnetic resonance–guided focused ultrasound (MRgFUS) trials targeting the anterior limb of the internal capsule have shown promising results. We evaluated the long-term safety and efficacy of MRgFUS capsulotomy in patients with obsessive-compulsive disorder (OCD) and major depressive disorder (MDD).
-
Unique Functional Neuroimaging Signatures of Genetic Versus Clinical High Risk for Psychosis Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-23 Charles H. Schleifer, Sarah E. Chang, Carolyn M. Amir, Kathleen P. O’Hora, Hoki Fung, Jee Won D. Kang, Leila Kushan-Wells, Eileen Daly, Fabio Di Fabio, Marianna Frascarelli, Maria Gudbrandsen, Wendy R. Kates, Declan Murphy, Jean Addington, Alan Anticevic, Kristin S. Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Matcheri Keshavan, Daniel H. Mathalon, Diana O. Perkins, William S. Stone, Elaine Walker
22q11.2 deletion syndrome (22qDel) is a copy number variant that is associated with psychosis and other neurodevelopmental disorders. Adolescents who are at clinical high risk for psychosis (CHR) are identified based on the presence of subthreshold psychosis symptoms. Whether common neural substrates underlie these distinct high-risk populations is unknown. We compared functional brain measures in
-
The Future of Disentangling the Heterogeneity of Autism With Neuroimaging Studies Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-23 Xujun Duan, Xiaolong Shan, Lucina Q. Uddin, Huafu Chen
Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition. Over the past decade, a considerable number of approaches have been developed to identify potential neuroimaging-based biomarkers of ASD that have uncovered specific neural mechanisms that underlie behaviors associated with ASD. However, the substantial heterogeneity among individuals who are diagnosed with ASD hinders the development
-
Corticotropin-Releasing Factor Release From a Unique Subpopulation of Accumbal Neurons Constrains Action-Outcome Acquisition in Reward Learning Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-22 Elizabeth A. Eckenwiler, Anna E. Ingebretson, Jeffrey J. Stolley, Maxine A. Fusaro, Alyssa M. Romportl, Jack M. Ross, Christopher L. Petersen, Eera M. Kale, Michael S. Clark, Selena S. Schattauer, Larry S. Zweifel, Julia C. Lemos
The nucleus accumbens (NAc) mediates reward learning and motivation. Despite an abundance of neuropeptides, peptidergic neurotransmission from the NAc has not been integrated into current models of reward learning. The existence of a sparse population of neurons containing corticotropin-releasing factor (CRF) has been previously documented. Here, we provide a comprehensive analysis of their identity
-
The Mechanisms of Persisting Disability in Schizophrenia: Imprecise Predictive Coding via Corticostriatothalamic-Cortical Loop Dysfunction Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-22 Peter F. Liddle, Musa B. Sami
Persisting symptoms and disability remain a problem for an appreciable proportion of people with schizophrenia despite treatment with antipsychotic medication. Improving outcomes requires an understanding of the nature and mechanisms of the pathological processes underlying persistence. Classical features of schizophrenia, which include disorganization and impoverishment of mental activity, are well-recognized
-
Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-22 Vibeke H. Dam, Kristin Köhler-Forsberg, Brice Ozenne, Søren V. Larsen, Cheng-Teng Ip, Anders Jorgensen, Dea S. Stenbæk, Jacob Madsen, Claus Svarer, Martin B. Jørgensen, Gitte M. Knudsen, Vibe G. Frokjaer
Brain serotonin 4 receptor (5-HT4R) levels are lower in untreated patients with major depressive disorder (MDD) and are linked to verbal memory. Here, we investigated the relationship between 5-HT4R levels, clinical outcomes, and cognitive function in patients with MDD who initiated selective serotonin reuptake inhibitor drug treatment.
-
Brain-Charting Autism and Attention-Deficit/Hyperactivity Disorder Reveals Distinct and Overlapping Neurobiology Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-14 Saashi A. Bedford, Meng-Chuan Lai, Michael V. Lombardo, Bhismadev Chakrabarti, Amber Ruigrok, John Suckling, Evdokia Anagnostou, Jason P. Lerch, Margot Taylor, Rob Nicolson, Georgiades Stelios, Jennifer Crosbie, Russell Schachar, Elizabeth Kelley, Jessica Jones, Paul D. Arnold, Eric Courchesne, Karen Pierce, Lisa T. Eyler, Kathleen Campbell, Cynthia Carter Barnes, Jakob Seidlitz, Aaron F. Alexander-Bloch
Autism and attention-deficit/hyperactivity disorder (ADHD) are heterogeneous neurodevelopmental conditions with complex underlying neurobiology that is still poorly understood. Despite overlapping presentation and sex-biased prevalence, autism and ADHD are rarely studied together and sex differences are often overlooked. Population modeling, often referred to as normative modeling, provides a unified
-
Maternal Antenatal Depression Is Associated With Metabolic Alterations That Predict Birth Outcomes and Child Neurodevelopment and Mental Health Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-08 Polina Girchenko, Marius Lahti-Pulkkinen, Hannele Laivuori, Eero Kajantie, Katri Räikkönen
Evidence regarding metabolic alterations associated with maternal antenatal depression (AD) is limited, and their role as potential biomarkers that improve the prediction of AD and adverse childbirth, neurodevelopmental, and mental health outcomes remains unexplored.
-
Sleep Deprivation Effects on Brain State Dynamics Are Associated With Dopamine D2 Receptor Availability Via Network Control Theory Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-08 Rui Zhang, Sukru Baris Demiral, Dardo Tomasi, Weizheng Yan, Peter Manza, Gene-Jack Wang, Nora D. Volkow
Sleep deprivation (SD) negatively affects brain function. Most brain imaging studies have investigated the effects of SD on static brain function. SD effects on functional brain dynamics and their relationship with molecular changes remain relatively unexplored.
-
Windows of Opportunity: How Age and Sex Shape the Influence of Prenatal Depression on the Child Brain Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-06 Kathryn Y. Manning, Aliza Jaffer, Catherine Lebel
Maternal prenatal depression can affect child brain and behavioral development. Specifically, altered limbic network structure and function is a likely mechanism through which prenatal depression impacts the life-long mental health of exposed children. While developmental trajectories are influenced by many factors that exacerbate risk or promote resiliency, the role of child age and sex in the relationship
-
Brain Network Localization of Gray Matter Atrophy and Neurocognitive and Social Cognitive Dysfunction in Schizophrenia Biol. Psychiatry (IF 9.6) Pub Date : 2024-08-03 Yan Cheng, Huanhuan Cai, Siyu Liu, Yang Yang, Shan Pan, Yongqi Zhang, Fan Mo, Yongqiang Yu, Jiajia Zhu
Numerous studies have established the presence of gray matter atrophy and brain activation abnormalities during neurocognitive and social cognitive tasks in schizophrenia. Despite a growing consensus that diseases localize better to distributed brain networks than individual anatomical regions, relatively few studies have examined brain network localization of gray matter atrophy and neurocognitive
-
Transcranial Magnetic Stimulation–Induced Plasticity Improving Cognitive Control in Obsessive-Compulsive Disorder, Part I: Clinical and Neuroimaging Outcomes From a Randomized Trial Biol. Psychiatry (IF 9.6) Pub Date : 2024-07-30 Sophie M.D.D. Fitzsimmons, Tjardo S. Postma, A. Dilene van Campen, Chris Vriend, Neeltje M. Batelaan, Patricia van Oppen, Adriaan W. Hoogendoorn, Ysbrand D. van der Werf, Odile A. van den Heuvel
Repetitive transcranial magnetic stimulation (rTMS) is an emerging treatment for obsessive-compulsive disorder (OCD). The neurobiological mechanisms of rTMS in OCD have been incompletely characterized. We compared clinical outcomes and changes in task-based brain activation following 3 different rTMS protocols, all combined with exposure and response prevention.
-
Dimensions of Early-Life Adversity Are Differentially Associated With Patterns of Delayed and Accelerated Brain Maturation Biol. Psychiatry (IF 9.6) Pub Date : 2024-07-29 Dani Beck, Lucy Whitmore, Niamh MacSweeney, Alexis Brieant, Valerie Karl, Ann-Marie G. de Lange, Lars T. Westlye, Kathryn L. Mills, Christian K. Tamnes
Different types of early-life adversity (ELA) have been associated with children’s brain structure and function. However, understanding the disparate influence of distinct adversity exposures on the developing brain remains a major challenge.
-
An Astroglial Basis of Major Depressive Disorder: Molecular, Cellular, and Circuit Features Biol. Psychiatry (IF 9.6) Pub Date : 2024-07-29 Cheng-Lin Lu, Jing Ren, Xiong Cao
Major depressive disorder is a common psychiatric disorder and a leading cause of disability worldwide. Astrocytes play a role in the maintenance of the function of the central nervous system, both physiologically and pathologically. Accumulated evidence indicates that the astrocyte is an important contributor to the pathophysiology of major depressive disorder including blood-brain barrier integrity
-
Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode Psychosis Biol. Psychiatry (IF 9.6) Pub Date : 2024-07-26 Sidhant Chopra, Priscila T. Levi, Alexander Holmes, Edwina R. Orchard, Ashlea Segal, Shona M. Francey, Brian O’Donoghue, Vanessa L. Cropley, Barnaby Nelson, Jessica Graham, Lara Baldwin, Hok Pan Yuen, Kelly Allott, Mario Alvarez-Jimenez, Susy Harrigan, Christos Pantelis, Stephen J. Wood, Patrick McGorry, Alex Fornito
Disruptions of axonal connectivity are thought to be a core pathophysiological feature of psychotic illness, but whether they are present early in the illness, prior to antipsychotic exposure, and whether they can predict clinical outcome remain unknown.